Novavax Third Quarter 2024 Financial Results and Operational Highlights

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings and more.

Shareholders seeking information can contact investor relations at (240) 268-2022 or contact us. 

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.